All In MedTech

Device Trial Radar · NCT07853716

REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care

Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care

Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Jun 2029

Study completion Jun 2029

Sponsor

Lead sponsor
HeartFlow, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Avania
First posted
Oct 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

REFINE-CAC is a prospective, multi-center trial assessing the management of asymptomatic participants with CAC scores 1-299 Agatston units or incidental CAC findings on chest computed tomography (CT), all of whom will undergo CCTA and are blinded to the coronary anatomy (e.g., % stenosis). The trial includes a randomized, controlled pathway and a single arm, observational registry pathway.

Conditions

  • CAD - Coronary Artery Disease

Interventions

  • Heartflow AnalysisDevice

    REFINE-CAC will provide Heartflow Analyses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants who initiate, intensify, cease, or de-escalate lipid lowering therapy (LLT)Time frame: Enrollment to 90 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • REFINE-CAC Trial Site

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.